“Likely” Merck Consumer Health Sale Could Bring $8 Billion – Analysts
This article was originally published in The Tan Sheet
Executive Summary
Merck executives shift their position about the potential divestiture of its non-pharma assets, including the consumer health business. J.P. Morgan analysts expect a sale of the consumer unit, and say Merck’s brands including Claritin and Coppertone could grow globally with a new owner.